Zurueck zur Suche

Reporte zur Charge X006981

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

20Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
GA 5 KY 3 KS 2 TN 2 PR 1 VA 1 MI 1 NY 1 MS 1

VAERS 2658633

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

schwer
Staat
PR
Alter
7,0
Geschlecht
M
Eingang
14.07.2023
Impfdatum
14.07.2023
Beginn
14.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Syncope Vision blurred

Symptomtext

The patient was vaccinated at 9:30 a.m. Mom left the office, I took him to a car and the patient expressed seeing cloudy vision and fainting on the pavement at 9:50 a.m.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Dyst. 176 B/P 102/59. 8-83
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
-
Vorherige Impfungen
-

VAERS 2684685

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge x006981

mild
Staat
KS
Alter
-
Geschlecht
M
Eingang
28.12.2023
Impfdatum
15.09.2023
Beginn
15.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling Vaccination site erythema Vaccination site swelling

Symptomtext

Patient was given MMR in the left thigh, the evening of the vaccine the vaccine site got red and swollen to the size of a quarter by the next day it was swollen to baseball size; Patient was given MMR in the left thigh, the evening of the vaccine the vaccine site got red and swollen to the size of a quarter by the next day it was swollen to baseball size; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2684685-1. The original narrative from the sender is the following: patient was given MMR in the left thigh, the evening of the vaccine the vaccine site got red and swollen to the size of a quarter by the next day it was swollen to baseball size. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events "Vaccination site erythema and Vaccination site swelling". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Eczema
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2717788

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

mild
Staat
-
Alter
40,0
Geschlecht
M
Eingang
25.11.2023
Impfdatum
25.11.2023
Beginn
25.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Nausea Nervousness Pallor

Symptomtext

Pt felt nauseous and was looking pale after 2 vaccines were administered. He was extremely nervous and hadn't eaten lunch. Gave pt water and some chocolate. He started to feel better within minutes, and I was able to administer the rest of the vaccines. He was fine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nausea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2713808

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge x006981

mild
Staat
TN
Alter
1,0
Geschlecht
F
Eingang
14.11.2023
Impfdatum
09.11.2023
Beginn
09.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site warmth

Symptomtext

Red area up to 6 cm and warm to touch noted around injection site of varicella (RUE) after 20 minutes. Area marked and receded after an additional 5 minutes. No difficulty breathing or rash. Pt then able to be DCd home. Refer to allergist

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2687291

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

mild
Staat
-
Alter
4,0
Geschlecht
F
Eingang
27.09.2023
Impfdatum
22.09.2023
Beginn
22.09.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site reaction Injection site urticaria Rash Urticaria Vomiting

Symptomtext

Patient developed red whelps/urticaria on left arm, then left leg, then right arm and leg within 2-3 minutes after vaccines were administered. Benadryl was given po and rash began to resolve within 10 minutes. No further symptoms developed that day. 3 days after the vaccines, patient had vomiting that lasted a few hours .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2680075

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

mild
Staat
GA
Alter
4,0
Geschlecht
M
Eingang
12.09.2023
Impfdatum
31.08.2023
Beginn
31.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cough Pharyngeal swelling Rash macular Sneezing Erythema

Symptomtext

4 years On Moms way out of the office after vaccination ~5minutes patient returned with sneezing and red blotchy face No vomiting or increased WOB Pt given benadryl PO

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash macular
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
TBI, epilepsy, developmental delay
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2680075

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge x006981

mild
Staat
GA
Alter
4,0
Geschlecht
M
Eingang
12.09.2023
Impfdatum
31.08.2023
Beginn
31.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cough Pharyngeal swelling Rash macular Sneezing Erythema

Symptomtext

4 years On Moms way out of the office after vaccination ~5minutes patient returned with sneezing and red blotchy face No vomiting or increased WOB Pt given benadryl PO

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash macular
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
TBI, epilepsy, developmental delay
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2677624

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge x006981

mild
Staat
KS
Alter
6,0
Geschlecht
F
Eingang
29.08.2023
Impfdatum
24.08.2023
Beginn
24.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Urticaria Vaccination site urticaria

Symptomtext

hives to the area vaccine was given, step mom gave her benadryl the next day

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
asthma
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2676726

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge x006981

mild
Staat
GA
Alter
21,0
Geschlecht
F
Eingang
25.08.2023
Impfdatum
19.08.2023
Beginn
20.08.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dry skin Rash erythematous Skin abrasion Skin exfoliation

Symptomtext

#non-specific rash erythematous, dry, scaly, excoriated rash, with regions of peeling appearing 1 day after varicella vaccine. pt denies itchiness, pain, burning, or systemic sx. Unclear etiology whether if rash 2/2 varicella vaccine or timing was coincidental. If were to treat with anti-viral, could stunt immune response to varicella vaccine. Given asx will do triamcinolone and have close f/u. -triamcionlone .1% BID -f/u in 1 week-- > if no improvement consider valacyclovir. -pt to send images to be imported in chart

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash erythematous
Hospital-Tage
-
Labordaten
triamcionlone 1% BID
Aktuelle Erkrankungen
none
Vorgeschichte
skin problems- not specified
Andere Medikamente
none
Allergien
Cephalosporins, Penicillin
Vorherige Impfungen
-

VAERS 2662623

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

mild
Staat
VA
Alter
23,0
Geschlecht
F
Eingang
28.07.2023
Impfdatum
26.07.2023
Beginn
27.07.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site pruritus Urticaria

Symptomtext

21 hours after vaccine, developed hives and itching at injection site, wrist and torso (bra line). no other sx

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
none known
Allergien
shrimp, lemons, tomatoes, onions, barley, yeast, grapefruit
Vorherige Impfungen
-

VAERS 2658372

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge x006981

mild
Staat
GA
Alter
1,3
Geschlecht
F
Eingang
19.07.2023
Impfdatum
18.07.2023
Beginn
18.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Irritability No adverse event Pyrexia Wrong product administered

Symptomtext

MMRV was given instead of MMR at the same time Varicella was given by mistake. No adverse reaction noted at this time. Mother states Patient has been fussy with low grade fever. She has given tylenol and motrin as need.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Tylenol, Motrin, Clartin
Allergien
None
Vorherige Impfungen
-

VAERS 2722523

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

gering
Staat
MI
Alter
24,0
Geschlecht
F
Eingang
09.12.2023
Impfdatum
09.12.2023
Beginn
09.12.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy Military service Pregnancy test positive Product use issue

Symptomtext

Patient inappropriately received the MMR and Varicella vaccines during a medical readiness event after testing positive with a urine hcg pregnancy test.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
Urine hcg
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Prenatal Vitamins
Allergien
-
Vorherige Impfungen
-

VAERS 2719037

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

gering
Staat
KY
Alter
1,3
Geschlecht
M
Eingang
29.11.2023
Impfdatum
03.11.2023
Beginn
03.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event

Symptomtext

No adverse effect documented

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2710408

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

gering
Staat
NY
Alter
13,0
Geschlecht
U
Eingang
06.11.2023
Impfdatum
01.07.2023
Beginn
01.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE; Physician calling to report a TE VARIVAX. HCP stated that the vaccines were administered to a patient on date of administration in July 2023.; This spontaneous report was received from a physician and referred to a 13-year-old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On an unspecified date in July 2023, the patient was vaccinated with improperly stored vaccine of varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot # X006981, expiry date: 07-MAR-2025), the second dose for the series (dose, strength and route of administration were not provided) for prophylaxis (Product storage error). The vaccine was exposed to 28 Fahrenheit (F)/14 F to 46 F for 15 minutes 0 seconds. There was no previous temperature excursion. No additional adverse event (AE) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2309USA007382:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2686010

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

gering
Staat
KY
Alter
-
Geschlecht
M
Eingang
25.09.2023
Impfdatum
01.09.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

HCP reported VARIVAX was administered after a temperature excursion to patient. Date of administration is Sep 1, 2023. No further information provided. No additional AE reported. No PQC reported. Names of vaccines involved (including lot/exp): VARIV; No addtional AE; This spontaneous report was received from a nurse and refers to a male patient of unknown age. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported. On 01-SEP-2023, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # X006981, expiration date: 07-MAR-2025), given once (dose, route of administration, anatomical location not provided) as prophylaxis, which underwent a temperature excursion at 6 Fahrenheit (F) during 20 minutes (product storage error). No additional adverse event (AE) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2685995

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

gering
Staat
KY
Alter
-
Geschlecht
U
Eingang
25.09.2023
Impfdatum
01.09.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

HCP reported VARIVAX was administered after a temperature excursion to patient. Date of administration is Sep 1, 2023. No further information provided. No additional AE reported. No PQC reported. Names of vaccines involved (including lot/exp): VARIV; No additional AE reported; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported. On 01-SEP-2023, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # X006981, expiration date: 07-MAR-2025), given once (dose, route of administration, anatomical location not provided) as prophylaxis, which underwent a temperature excursion at 6 Fahrenheit (F) during 20 minutes (product storage error). No additional adverse event (AE) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2685211

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

gering
Staat
TN
Alter
4,0
Geschlecht
F
Eingang
22.09.2023
Impfdatum
22.09.2023
Beginn
22.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient Recieved Varivax vaccine as well as MMRV vaccine during the same visit.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2673441

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

gering
Staat
-
Alter
0,3
Geschlecht
F
Eingang
18.08.2023
Impfdatum
15.08.2023
Beginn
15.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

No signs or symptoms noticed at time of administration. There was no reaction to the given vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2670980

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
14.08.2023
Impfdatum
18.07.2023
Beginn
18.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Overdose

Symptomtext

No Additional AE; HCP called to report that the patient was administered PROQUAD and VARIVAX in the same day. No Additional AE/PQC.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information on patient's medical history, current conditions and concomitant medications was provided. On 18-JUL-2023 the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (albumin status: rHA) lot # w039840 and expiration date 12-JUN-2024, 0.5 milliliter for prophylaxis (dose number, route and site of administration were not provided) and varicella virus vaccine live (oka/merck)(VARIVAX) lot # x006981 (valid for varicella virus vaccine live (oka/merck)(VARIVAX)) and expiration date established as 07-MAR-2025, 0.5 milliliter for prophylaxis (dose number, route and site of administration were not provided) (overdose and no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2670923

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge X006981

gering
Staat
MS
Alter
5,0
Geschlecht
M
Eingang
14.08.2023
Impfdatum
02.08.2023
Beginn
02.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Somnolence Unresponsive to stimuli Urinary incontinence

Symptomtext

At 14:40 mom returns to clinic with child saying he is having a reaction to vaccines. Patient is awake but drowsy and talking. Mom states " he became unresponsive in drive thru line." Child also urinated on himself. Patient has 2-3 small red spots on chest and 2-3 small red spots on upper back. Does not have labored breathing and child states does not feel short of breath. Benadryl given per standing orders. BP at 14:45 was 130/82. rechecked BP at 15:00 it was 118/60. Patient becoming more active. Talking the whole time. Mom states history of febrile seizures. Last one 5 months ago. No new red spots appearing on body. Patient is alert and active. Encouraged mom to watch child closely. To ER if condition worsens. Mom verbalized understanding. Patient walked out with mom.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
History of febrile seizures
Andere Medikamente
None
Allergien
PCN, Cephalosporins
Vorherige Impfungen
-